Want to see KLRS full AI Analyst Report?
Kalaris Therapeutics (KLRS) Ownership - Who Owns Kalaris Therapeutics?
Kalaris Therapeutics (KLRS) Ownership Overview
- 54.44% Insiders
- 1.98% Mutual Funds
- 4.37% Other Institutional Investors
- 1.14% ETFs
- 38.07% Public Companies and Individual Investors
The ownership structure of Kalaris Therapeutics (KLRS) stock is a mix of institutional, retail, and individual investors. Approximately 7.49% of the company’s stock is owned by Institutional Investors, 54.44% is owned by Insiders, and 38.07% is owned by Public Companies and Individual Investors.
The ownership structure of Kalaris Therapeutics (KLRS) stock is a mix of institutional, retail, and individual investors. Approximately 6.35% of the company’s stock is owned by Institutional Investors, 54.44% is owned by Insiders, and 1.14% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 21, 2026 | Srinivas Akkaraju | $1,179,969 | |
| Mar 22, 2026 | Brett R Hagen | $12,869 | |
| Feb 16, 2026 | Srinivas Akkaraju | $5,000,006 |
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| David Hallal | 19,677,546 | Insider | 82.66% | 39,945,418 |
| Srinivas Akkaraju | 12,915,520 | Insider | 54.26% | 26,218,506 |
| Ferrara Napoleone | 504,000 | Insider | 2.12% | 1,023,120 |
| Vanguard Index Funds | 392,710 | Institution | 1.65% | 797,201 |
| Vanguard | 324,926 | Institution | 1.36% | 659,600 |
| Michael Rockefeller | 100,000 | Institution | 0.42% | 203,000 |
| Fidelity Concord Street Trust | 93,856 | Institution | 0.39% | 190,528 |
| Fidelity Commonwealth Trust Ii | 74,608 | Institution | 0.31% | 151,454 |
| Bridgeway Funds, Inc. | 32,500 | Institution | 0.14% | 65,975 |
| Northern Funds | 30,838 | Institution | 0.13% | 62,601 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 392,710 | Institution | 1.65% | 797,201 |
| Fidelity Concord Street Trust | 93,856 | Institution | 0.39% | 190,528 |
| Fidelity Commonwealth Trust Ii | 74,608 | Institution | 0.31% | 151,454 |
| Bridgeway Funds, Inc. | 32,500 | Institution | 0.14% | 65,975 |
| Northern Funds | 30,838 | Institution | 0.13% | 62,601 |
| Goldman Sachs Trust | 30,074 | Institution | 0.13% | 61,050 |
| Vanguard Valley Forge Funds | 6,002 | Institution | 0.03% | 12,184 |
| Fidelity Rutland Square Trust Ii | 5,300 | Institution | 0.02% | 10,759 |
| Victory Portfolios Iii | 4,994 | Institution | 0.02% | 10,138 |
| Dfa Investment Dimensions Group Inc | 2,750 | Institution | 0.01% | 5,582 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 255,337 | Institution | 1.07% | 737,924 |
| Vanguard | 69,589 | Institution | 0.29% | 201,112 |
| iShares | 27,597 | Institution | 0.12% | 58,782 |
| Bridgeway | 22,500 | Institution | 0.09% | 47,925 |
| DFA | 3,296 | Institution | 0.01% | 7,020 |
| DFA | 2,614 | Institution | 0.01% | 5,568 |
| - | 384 | Institution | <0.01% | 1,065 |
| - | 255 | Institution | <0.01% | 707 |
| Dimensional | 100 | Institution | <0.01% | 213 |
FAQ
Who Owns Kalaris Therapeutics (KLRS)?
According to the latest TipRanks data, approximately 4.37% of the company's stock is held by institutional investors, 54.44% is held by insiders, and 38.07% is held by retail investors.
What percentage of Kalaris Therapeutics (KLRS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.37% of Kalaris Therapeutics (KLRS) stock is held by institutional investors.
What percentage of Kalaris Therapeutics (KLRS) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.07% of Kalaris Therapeutics (KLRS) stock is held by retail investors.
Who owns the most shares of Kalaris Therapeutics (KLRS)?
David Hallal owns the most shares of Kalaris Therapeutics (KLRS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.